NVDL Insider Trading Activity and SEC Form 4 Filings
NVDL insider trading summary
No open-market insider purchases or sales of Novadel Pharma Inc (NVDL) have been reported on SEC Form 4 in the past 12 months.
Latest NVDL insider buys and sells
| Date | Insider | Role | Type | Value |
|---|---|---|---|---|
| Mar 31, 2010 | Jay Moorin | 10% Owner | Buy | $800K (4,848,485 @ $0.17) |
| Mar 31, 2010 | Proquest Investments II Advisors Fund LP | 10% Owner | Buy | $800K (4,848,485 @ $0.17) |
| Mar 31, 2010 | ProQuest Investments III, L.P. | 10% Owner | Buy | $800K (4,848,485 @ $0.17) |
| Mar 31, 2010 | Alain Schreiber | 10% Owner | Buy | $800K (4,848,485 @ $0.17) |
| Mar 31, 2010 | Proquest Investments II LP | 10% Owner | Buy | $800K (4,848,485 @ $0.17) |
| Mar 31, 2010 | ProQuest Associates III LLC | 10% Owner | Buy | $800K (4,848,485 @ $0.17) |
| Mar 31, 2010 | Proquest Associates II LLC | 10% Owner | Buy | $800K (4,848,485 @ $0.17) |
Source: SEC Form 4 filings. Open-market purchases (code P) and sales (code S) only; option exercises, grants and gifts are excluded.